<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39062549</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>11</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Interplay between Comorbidities and Long COVID: Challenges and Multidisciplinary Approaches.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">835</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom14070835</ELocationID><Abstract><AbstractText>Long COVID, a name often given to the persistent symptoms following acute SARS-CoV-2 infection, poses a multifaceted challenge for health. This review explores the intrinsic relationship between comorbidities and autoimmune responses in shaping the trajectory of long COVID. Autoantibodies have emerged as significant players in COVID-19 pathophysiology, with implications for disease severity and progression. Studies show immune dysregulation persisting months after infection, marked by activated innate immune cells and high cytokine levels. The presence of autoantibodies against various autoantigens suggests their potential as comorbid factors in long COVID. Additionally, the formation of immune complexes may lead to severe disease progression, highlighting the urgency for early detection and intervention. Furthermore, long COVID is highly linked to cardiovascular complications and neurological symptoms, posing challenges in diagnosis and management. Multidisciplinary approaches, including vaccination, tailored rehabilitation, and pharmacological interventions, are used for mitigating long COVID's burden. However, numerous challenges persist, from evolving diagnostic criteria to addressing the psychosocial impact and predicting disease outcomes. Leveraging AI-based applications holds promise in enhancing patient management and improving our understanding of long COVID. As research continues to unfold, unravelling the complexities of long COVID remains paramount for effective intervention and patient care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ashmawy</LastName><ForeName>Rasha</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2689-5968</Identifier><AffiliationInfo><Affiliation>Clinical Research Administration, Directorate of Health Affairs, Ministry of Health and Population, Alexandria 21554, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Informatics and Medical Statistics, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammouda</LastName><ForeName>Esraa Abdellatif</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0003-3269-6623</Identifier><AffiliationInfo><Affiliation>Biomedical Informatics and Medical Statistics, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Department, El-Raml Pediatric Hospital, Ministry of Health and Population, Alexandria 21563, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Maradny</LastName><ForeName>Yousra A</ForeName><Initials>YA</Initials><Identifier Source="ORCID">0000-0001-9501-8059</Identifier><AffiliationInfo><Affiliation>Pharmaceutical and Fermentation Industries Development Center, City of Scientific Research and Technological Applications (SRTA-City), New Borg EL-Arab 21934, Alexandria, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology and Immunology, Faculty of Pharmacy, Arab Academy for Science, Technology and Maritime Transport (AASTMT), El-Alamein Campus, Aswan 51718, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aboelsaad</LastName><ForeName>Iman</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-9412-1668</Identifier><AffiliationInfo><Affiliation>Clinical Research Administration, Directorate of Health Affairs, Ministry of Health and Population, Alexandria 21554, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussein</LastName><ForeName>Mai</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Research Administration, Directorate of Health Affairs, Ministry of Health and Population, Alexandria 21554, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uversky</LastName><ForeName>Vladimir N</ForeName><Initials>VN</Initials><Identifier Source="ORCID">0000-0002-4037-5857</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine and USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redwan</LastName><ForeName>Elrashdy M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0001-8246-0075</Identifier><AffiliationInfo><Affiliation>Department of Biological Science, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Therapeutic and Protective Proteins Laboratory, Protein Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, New Borg EL-Arab 21934, Alexandria, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="Y">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">autoantibodies</Keyword><Keyword MajorTopicYN="N">comorbidities</Keyword><Keyword MajorTopicYN="N">interplay</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">synergistic effects</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>28</Day><Hour>14</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39062549</ArticleId><ArticleId IdType="pmc">PMC11275036</ArticleId><ArticleId IdType="doi">10.3390/biom14070835</ArticleId><ArticleId IdType="pii">biom14070835</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Faramarzi A., Norouzi S., Dehdarirad H., Aghlmand S., Yusefzadeh H., Javan-Noughabi J. The global economic burden of COVID-19 disease: A comprehensive systematic review and meta-analysis. Syst. Rev. 2024;13:68. doi: 10.1186/s13643-024-02476-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-024-02476-6</ArticleId><ArticleId IdType="pmc">PMC10870589</ArticleId><ArticleId IdType="pubmed">38365735</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B., Siqueira S., de Assis Soares W.R., de Souza Rangel F., Santos N.O., Dos Santos Freitas A., da Silveira P.R., Tiwari S., Alzahrani K.J., G&#xf3;es-Neto A., et al. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 2021;13:700. doi: 10.3390/v13040700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. How common is long COVID? Why studies give different answers. Nature. 2022;606:852&#x2013;853. doi: 10.1038/d41586-022-01702-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-01702-2</ArticleId><ArticleId IdType="pubmed">35725828</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Center of Disease Control and Prevention (CDC)  Long COVID or Post-COVID Conditions.  [(accessed on 10 February 2024)];2023  Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Bull-Otterson L., Baca S., Saydah S., Boehmer T.K., Adjei S., Gray S., Harris A.M. Post-COVID Conditions among Adult COVID-19 Survivors Aged 18&#x2013;64 and &#x2265;65 Years&#x2014;United States, March 2020&#x2013;November 2021. MMWR Morb. Mortal Wkly. Rep. 2022;71:713&#x2013;717. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bosworth M.L., King S., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N.A., Walker A.S., editors. Open Forum Infectious Diseases. Oxford University Press; New York, NY, USA: 2022. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: Community-based, matched cohort study.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D.M., Whettlock E.M., Liu S., Arachchillage D.J., Boyton R.J. The immunology of long COVID. Nat. Rev. Immunol. 2023;23:618&#x2013;634. doi: 10.1038/s41577-023-00904-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi M.S., Omrani O.A., Fawzy N.A., Shaar B.A., Almamlouk R., Riaz M., Obeidat M., Obeidat Y., Gerberi D., Taha R.M., et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2022;28:657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelman B., Charlton B.T., Goulding R.P., Kerkhoff T.J., Breedveld E.A., Noort W., Offringa C., Bloemers F.W., van Weeghel M., Schomakers B.V., et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat. Commun. 2024;15:17. doi: 10.1038/s41467-023-44432-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-44432-3</ArticleId><ArticleId IdType="pmc">PMC10766651</ArticleId><ArticleId IdType="pubmed">38177128</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. Risks and burdens of incident diabetes in long COVID: A cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;321. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S., Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;269. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawilska J.B., Kuczynska K. Psychiatric and neurological complications of long COVID. J. Psychiatr. Res. 2022;156:349&#x2013;360. doi: 10.1016/j.jpsychires.2022.10.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.10.045</ArticleId><ArticleId IdType="pmc">PMC9582925</ArticleId><ArticleId IdType="pubmed">36326545</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitroi R.M., Padureanu V., Mitrea A., Protasiewicz Timofticiuc D.C., Rosu M.M., Clenciu D., Enescu A., Padureanu R., Tenea Cojan T.S., Vladu I.M. Prothrombotic status in COVID-19 with diabetes mellitus. Biomed. Rep. 2023;19:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10463232</ArticleId><ArticleId IdType="pubmed">37649534</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinescu-Bercu A., Lobiuc A., C&#x103;liman-Sturdza O.A., Oi&#x163;&#x103; R.C., Iavorschi M., Pav&#x103;l N.-E., &#x218;old&#x103;nescu I., Dimian M., Covasa M. Long COVID: Molecular Mechanisms and Detection Techniques. Int. J. Mol. Sci. 2024;25:408. doi: 10.3390/ijms25010408.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25010408</ArticleId><ArticleId IdType="pmc">PMC10778767</ArticleId><ArticleId IdType="pubmed">38203577</ArticleId></ArticleIdList></Reference><Reference><Citation>Takakura K., Suka M., Kajihara M., Koido S. Clinical features, therapeutic outcomes, and recovery period of long COVID. J. Med. Virol. 2023;95:e28316. doi: 10.1002/jmv.28316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28316</ArticleId><ArticleId IdType="pmc">PMC10108287</ArticleId><ArticleId IdType="pubmed">36412057</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Sivan M., Delaney B., Evans R., Milne R. Long covid-an update for primary care. BMJ. 2022;378:e072117. doi: 10.1136/bmj-2022-072117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072117</ArticleId><ArticleId IdType="pubmed">36137612</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Maradny Y.A., Rubio-Casillas A., Uversky V.N., Redwan E.M. Intrinsic factors behind long-COVID: I. Prevalence of the extracellular vesicles. J. Cell. Biochem. 2023;124:656&#x2013;673. doi: 10.1002/jcb.30415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.30415</ArticleId><ArticleId IdType="pubmed">37126363</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Maradny Y.A., Rubio-Casillas A., Mohamed K.I., Uversky V.N., Redwan E.M. Intrinsic factors behind long-COVID: II. SARS-CoV-2, extracellular vesicles, and neurological disorders. J. Cell. Biochem. 2023;124:1466&#x2013;1485. doi: 10.1002/jcb.30486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.30486</ArticleId><ArticleId IdType="pubmed">37801299</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Baky N.A., Amara A.A., Uversky V.N., Redwan E.M. Intrinsic factors behind long COVID: III. Persistence of SARS-CoV-2 and its components. J. Cell. Biochem. 2024;125:22&#x2013;44. doi: 10.1002/jcb.30514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.30514</ArticleId><ArticleId IdType="pubmed">38098317</ArticleId></ArticleIdList></Reference><Reference><Citation>Eltayeb A., Al-Sarraj F., Alharbi M., Albiheyri R., Mattar E.H., Abu Zeid I.M., Bouback T.A., Bamagoos A., Uversky V.N., Rubio-Casillas A. Intrinsic factors behind long COVID: IV. Hypothetical roles of the SARS-CoV-2 nucleocapsid protein and its liquid&#x2013;liquid phase separation. J. Cell. Biochem. 2024;125:e30530. doi: 10.1002/jcb.30530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.30530</ArticleId><ArticleId IdType="pubmed">38349116</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma C., Bayry J. High risk of autoimmune diseases after COVID-19. Nat. Rev. Rheumatol. 2023;19:399&#x2013;400. doi: 10.1038/s41584-023-00964-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-023-00964-y</ArticleId><ArticleId IdType="pmc">PMC10096101</ArticleId><ArticleId IdType="pubmed">37046064</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M., Rodriguez Y., Acosta-Ampudia Y., Monsalve D.M., Zhu C., Li Q.Z., Ramirez-Santana C., Anaya J.M. Autoimmunity is a hallmark of post-COVID syndrome. J. Transl. Med. 2022;20:129. doi: 10.1186/s12967-022-03328-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J. Investig. Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur J.M., Forrest J.C., Boehme K.W., Kennedy J.L., Owens S., Herzog C., Liu J., Harville T.O. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS ONE. 2021;16:e0257016. doi: 10.1371/journal.pone.0257016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., F&#xfc;rst J., Schulze-Rothe S., Wallukat A., Honicke A.S., Muller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J. Transl. Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Cristanziano V.D., Osebold L., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Abell&#xe1;n J., Padilla S., Fern&#xe1;ndez-Gonz&#xe1;lez M., Garc&#xed;a J.A., Agull&#xf3; V., Andreo M., Ruiz S., Galiana A., Guti&#xe9;rrez F., Masi&#xe1; M. Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: A longitudinal study. J. Clin. Immunol. 2021;41:1490&#x2013;1501. doi: 10.1007/s10875-021-01083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01083-7</ArticleId><ArticleId IdType="pmc">PMC8285689</ArticleId><ArticleId IdType="pubmed">34273064</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorchenko Y., Zimba O. Long COVID in autoimmune rheumatic diseases. Rheumatol. Int. 2023;43:1197&#x2013;1207. doi: 10.1007/s00296-023-05319-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-023-05319-0</ArticleId><ArticleId IdType="pmc">PMC10061411</ArticleId><ArticleId IdType="pubmed">36995436</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinones-Moya H., Ocampo-Del Valle A., Camargo-Coronel A., Jim&#xe9;nez-Balderas F.J., Bernal-Enriquez M.B., Madinabeitia-Rodr&#xed;guez P., Morales-Medino K.N., Roque-Ibanez C., Hern&#xe1;ndez-Zavala M.R. Long COVID in patients with rheumatologic disease: A single center observational study. Indian J. Rheumatol. 2023;18:212&#x2013;217. doi: 10.4103/injr.injr_118_22.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/injr.injr_118_22</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes L.A., Agrawal D.K. Thromboembolism in the Complications of Long COVID-19. Cardiol. Cardiovasc. Med. 2023;7:123&#x2013;128. doi: 10.26502/fccm.92920317.</Citation><ArticleIdList><ArticleId IdType="doi">10.26502/fccm.92920317</ArticleId><ArticleId IdType="pmc">PMC10310316</ArticleId><ArticleId IdType="pubmed">37389402</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah B., Ahmad M.N., Khalid M., Minhas A., Ali R., Sarfraz Z., Sarfraz A. Long COVID and Wavering Incidence of Pulmonary Embolism: A Systematic Review. J. Community Hosp. Intern. Med. Perspect. 2023;13:23&#x2013;31. doi: 10.55729/2000-9666.1233.</Citation><ArticleIdList><ArticleId IdType="doi">10.55729/2000-9666.1233</ArticleId><ArticleId IdType="pmc">PMC10589046</ArticleId><ArticleId IdType="pubmed">37868668</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K., Jamil R., Chowdhury A., Mukherjee M., Venegas C., Miyasaki K., Zhang K., Patel Z., Salter B., Yuen A.C.Y., et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur. Respir. J. 2023;61:2200970. doi: 10.1183/13993003.00970-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczykowski C., Mardin C., Lucio M., Wallukat G., Hoffmanns J., Schr&#xf6;der T., Raith F., Rogge L., Heltmann F., Moritz M., et al. Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation. Int. J. Mol. Sci. 2022;23:7209. doi: 10.3390/ijms23137209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137209</ArticleId><ArticleId IdType="pmc">PMC9266742</ArticleId><ArticleId IdType="pubmed">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurner L., Fadle N., Regitz E., Preuss K.-D., Neumann F., Cetin O., Schormann C., Hoffmann M.-C., Herr C., Kheiroddin P., et al. Autoantibodies against SUMO1-DHX35 in long-COVID. J. Transl. Autoimmun. 2022;5:100171. doi: 10.1016/j.jtauto.2022.100171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2022.100171</ArticleId><ArticleId IdType="pmc">PMC9675633</ArticleId><ArticleId IdType="pubmed">36425003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kattah N.H., Kattah M.G., Utz P.J. The U1-snRNP complex: Structural properties relating to autoimmune pathogenesis in rheumatic diseases. Immunol. Rev. 2010;233:126&#x2013;145. doi: 10.1111/j.0105-2896.2009.00863.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2009.00863.x</ArticleId><ArticleId IdType="pmc">PMC3074261</ArticleId><ArticleId IdType="pubmed">20192997</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo G. COVID-19 as an immune complex hypersensitivity in antigen excess conditions: Theoretical pathogenetic process and suggestions for potential therapeutic interventions. Front. Immunol. 2020;11:566000. doi: 10.3389/fimmu.2020.566000.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.566000</ArticleId><ArticleId IdType="pmc">PMC7609482</ArticleId><ArticleId IdType="pubmed">33193337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.M., Kim Y., Seo J.W., Lee J., Park U., Ha N.Y., Koh J., Park H., Lee J.W., Ro H.J., et al. Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19. Cell Rep. 2021;37:109798. doi: 10.1016/j.celrep.2021.109798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109798</ArticleId><ArticleId IdType="pmc">PMC8450316</ArticleId><ArticleId IdType="pubmed">34587481</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty S., Gonzalez J., Edwards K., Mallajosyula V., Buzzanco A.S., Sherwood R., Buffone C., Kathale N., Providenza S., Xie M.M., et al. Proinflammatory IgG Fc structures in patients with severe COVID-19. Nat. Immunol. 2021;22:67&#x2013;73. doi: 10.1038/s41590-020-00828-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00828-7</ArticleId><ArticleId IdType="pmc">PMC8130642</ArticleId><ArticleId IdType="pubmed">33169014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolb P., Giese S., Voll R.E., Hengel H., Falcone V. Immune complexes as culprits of immunopathology in severe COVID-19. Med. Microbiol. Immunol. 2023;212:185&#x2013;191. doi: 10.1007/s00430-022-00743-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-022-00743-8</ArticleId><ArticleId IdType="pmc">PMC9308473</ArticleId><ArticleId IdType="pubmed">35871171</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutanto H., Soegiarto G. Risk of Thrombosis during and after a SARS-CoV-2 Infection: Pathogenesis, Diagnostic Approach, and Management. Hematol. Rep. 2023;15:225&#x2013;243. doi: 10.3390/hematolrep15020024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/hematolrep15020024</ArticleId><ArticleId IdType="pmc">PMC10123679</ArticleId><ArticleId IdType="pubmed">37092518</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Yu C., Jing H., Wu X., Novakovic V.A., Xie R., Shi J. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation. Front. Cell. Infect. Microbiol. 2022;12:861703. doi: 10.3389/fcimb.2022.861703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight J.S., Caricchio R., Casanova J.L., Combes A.J., Diamond B., Fox S.E., Hanauer D.A., James J.A., Kanthi Y., Ladd V., et al. The intersection of COVID-19 and autoimmunity. J. Clin. Investig. 2021;131:e154886. doi: 10.1172/JCI154886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI154886</ArticleId><ArticleId IdType="pmc">PMC8670833</ArticleId><ArticleId IdType="pubmed">34710063</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Zuo M., Yalavarthi S., Gockman K., Madison J.A., Shi H., Woodard W., Lezak S.P., Lugogo N.L., Knight J.S., et al. Neutrophil extracellular traps and thrombosis in COVID-19. J. Thromb. Thrombolysis. 2021;51:446&#x2013;453. doi: 10.1007/s11239-020-02324-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02324-z</ArticleId><ArticleId IdType="pmc">PMC7642240</ArticleId><ArticleId IdType="pubmed">33151461</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;nge B.L., Hermansen M.-L.F., Storgaard M. Reactive arthritis after COVID-19. BMJ Case Rep. CP. 2021;14:e241375. doi: 10.1136/bcr-2020-241375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-241375</ArticleId><ArticleId IdType="pmc">PMC7929821</ArticleId><ArticleId IdType="pubmed">33653867</ArticleId></ArticleIdList></Reference><Reference><Citation>Batur E.B., Korez M.K., Gezer I.A., Levendoglu F., Ural O. Musculoskeletal symptoms and relationship with laboratory findings in patients with COVID-19. Int. J. Clin. Pract. 2021;75:e14135. doi: 10.1111/ijcp.14135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14135</ArticleId><ArticleId IdType="pmc">PMC8250333</ArticleId><ArticleId IdType="pubmed">33686741</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota H.R., Nune A. Long COVID from rheumatology perspective&#x2014;A narrative review. Clin. Rheumatol. 2022;41:337&#x2013;348. doi: 10.1007/s10067-021-06001-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-06001-1</ArticleId><ArticleId IdType="pmc">PMC8629735</ArticleId><ArticleId IdType="pubmed">34845562</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyongyosi M., Alcaide P., Asselbergs F.W., Brundel B., Camici G.G., Martins P.D.C., Ferdinandy P., Fontana M., Girao H., Gnecchi M., et al. Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: A joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovasc. Res. 2023;119:336&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="pubmed">35875883</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerma L.A., Chaudhary A., Bryan A., Morishima C., Wener M.H., Fink S.L. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19) J. Transl. Autoimmun. 2020;3:100073. doi: 10.1016/j.jtauto.2020.100073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2020.100073</ArticleId><ArticleId IdType="pmc">PMC7691817</ArticleId><ArticleId IdType="pubmed">33263103</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouranloo K., Dey M., Elwell H., Nune A. A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19. Rheumatol. Int. 2023;43:1221&#x2013;1243. doi: 10.1007/s00296-023-05283-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-023-05283-9</ArticleId><ArticleId IdType="pmc">PMC9927056</ArticleId><ArticleId IdType="pubmed">36786873</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente-Ros M., Das S., Elias J., Frishman W.H., Aronow W.S. Cardiovascular Manifestations of the Long COVID Syndrome. Cardiol. Rev. 2023 online ahead of print .</Citation><ArticleIdList><ArticleId IdType="pubmed">37071080</ArticleId></ArticleIdList></Reference><Reference><Citation>Goerlich E., Chung T.H., Hong G.H., Metkus T.S., Gilotra N.A., Post W.S., Hays A.G. Cardiovascular effects of the post-COVID-19 condition. Nat. Cardiovasc. Res. 2024;3:118&#x2013;129. doi: 10.1038/s44161-023-00414-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44161-023-00414-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolu-Akinnawo O., Adusei Poku F., Elimihele T., League M., Adkins C.F., Okafor H. Acute Cardiovascular Complications of COVID-19: A Systematic Review. Cureus. 2023;15:e38576. doi: 10.7759/cureus.38576.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.38576</ArticleId><ArticleId IdType="pmc">PMC10166388</ArticleId><ArticleId IdType="pubmed">37168413</ArticleId></ArticleIdList></Reference><Reference><Citation>Terzic C.M., Medina-Inojosa B.J. Cardiovascular Complications of Coronavirus Disease-2019. Phys. Med. Rehabil. Clin. N. Am. 2023;34:551&#x2013;561. doi: 10.1016/j.pmr.2023.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmr.2023.03.003</ArticleId><ArticleId IdType="pmc">PMC10063539</ArticleId><ArticleId IdType="pubmed">37419531</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremonesi M., Felicetta A., Cannata F., Serio S., van Beek J.J.P., Bombace S., My I., Zanon V., Catalano C., Papadopoulou V., et al. Long COVID-19 Cardiac Complications Are Associated with Autoimmunity to Cardiac Self-Antigens Sufficient to Cause Cardiac Dysfunction. Circulation. 2023;148:504&#x2013;507. doi: 10.1161/CIRCULATIONAHA.122.062672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.062672</ArticleId><ArticleId IdType="pubmed">37549204</ArticleId></ArticleIdList></Reference><Reference><Citation>Sander L.E., Garaude J. The mitochondrial respiratory chain: A metabolic rheostat of innate immune cell-mediated antibacterial responses. Mitochondrion. 2018;41:28&#x2013;36. doi: 10.1016/j.mito.2017.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2017.10.008</ArticleId><ArticleId IdType="pubmed">29054472</ArticleId></ArticleIdList></Reference><Reference><Citation>Adebayo A., Varzideh F., Wilson S., Gambardella J., Eacobacci M., Jankauskas S.S., Donkor K., Kansakar U., Trimarco V., Mone P., et al. l-Arginine and COVID-19: An Update. Nutrients. 2021;13:3951. doi: 10.3390/nu13113951.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113951</ArticleId><ArticleId IdType="pmc">PMC8619186</ArticleId><ArticleId IdType="pubmed">34836206</ArticleId></ArticleIdList></Reference><Reference><Citation>DePace N.L., Colombo J. Long-COVID Syndrome and the Cardiovascular System: A Review of Neurocardiologic Effects on Multiple Systems. Curr. Cardiol. Rep. 2022;24:1711&#x2013;1726. doi: 10.1007/s11886-022-01786-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-022-01786-2</ArticleId><ArticleId IdType="pmc">PMC9524329</ArticleId><ArticleId IdType="pubmed">36178611</ArticleId></ArticleIdList></Reference><Reference><Citation>Czeisler M.E., Ibrahim S.A. Cardiovascular Risks in Patients with Post-COVID-19 Condition. JAMA Health Forum. 2023;4:e224664. doi: 10.1001/jamahealthforum.2022.4664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.4664</ArticleId><ArticleId IdType="pubmed">36867422</ArticleId></ArticleIdList></Reference><Reference><Citation>Golchin Vafa R., Heydarzadeh R., Rahmani M., Tavan A., Khoshnoud Mansorkhani S., Zamiri B., Amiri F., Azadian A., Khademolhosseini A., Montaseri M., et al. The long-term effects of the COVID-19 infection on cardiac symptoms. BMC Cardiovasc. Disord. 2023;23:286. doi: 10.1186/s12872-023-03322-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-023-03322-8</ArticleId><ArticleId IdType="pmc">PMC10243271</ArticleId><ArticleId IdType="pubmed">37280530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-covid syndrome in individuals admitted to hospital with COVID-19: Retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Bowe B., Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 2021;12:6571. doi: 10.1038/s41467-021-26513-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanne J.P., Little B.P., Schulte J.J., Haramati A., Haramati L.B. Long-term Lung Abnormalities Associated with COVID-19 Pneumonia. Radiology. 2023;306:e221806. doi: 10.1148/radiol.221806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.221806</ArticleId><ArticleId IdType="pmc">PMC9462591</ArticleId><ArticleId IdType="pubmed">36040336</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;rnberg A., Svensson-Raskh A., Rydwik E., Bj&#xf6;rnsson M., Runold M., Bruchfeld J., Nygren-Bonnier M., Hallberg C.E. Twenty months follow-up in non-hospitalised adults with post COVID-19 condition: A preliminary longitudinal cohort study. Eur. Respir. J. 2022;60:4637.</Citation></Reference><Reference><Citation>B&#xf8;rvik T., Evensen L.H., Morelli V.M., Melbye H., Br&#xe6;kkan S.K., Hansen J.B. Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism&#x2014;The Troms&#xf8; study. Res. Pract. Thromb. Haemost. 2020;4:255&#x2013;262. doi: 10.1002/rth2.12299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12299</ArticleId><ArticleId IdType="pmc">PMC7040548</ArticleId><ArticleId IdType="pubmed">32110756</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaaya G., Vishnubhotla P. Pulmonary Vein Thrombosis: A Recent Systematic Review. Cureus. 2017;9:e993. doi: 10.7759/cureus.993.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.993</ArticleId><ArticleId IdType="pmc">PMC5323025</ArticleId><ArticleId IdType="pubmed">28265529</ArticleId></ArticleIdList></Reference><Reference><Citation>Vyas V., Goyal A. Acute Pulmonary Embolism. StatPearls Publishing; Treasure Island, FL, USA: 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32809386</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariri L.P., North C.M., Shih A.R., Israel R.A., Maley J.H., Villalba J.A., Vinarsky V., Rubin J., Okin D.A., Sclafani A. Lung histopathology in coronavirus disease 2019 as compared with severe acute respiratory sydrome and H1N1 influenza: A systematic review. Chest. 2021;159:73&#x2013;84. doi: 10.1016/j.chest.2020.09.259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.09.259</ArticleId><ArticleId IdType="pmc">PMC7538870</ArticleId><ArticleId IdType="pubmed">33038391</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerahandi H., Hochman K.A., Simon E., Blaum C., Chodosh J., Duan E., Garry K., Kahan T., Karmen-Tuohy S.L., Karpel H.C., et al. Post-Discharge Health Status and Symptoms in Patients with Severe COVID-19. J. Gen. Intern. Med. 2021;36:738&#x2013;745. doi: 10.1007/s11606-020-06338-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-06338-4</ArticleId><ArticleId IdType="pmc">PMC7808113</ArticleId><ArticleId IdType="pubmed">33443703</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceccarini M.R., Bonetti G., Medori M.C., Dhuli K., Tezzele S., Micheletti C., Maltese P.E., Cecchin S., Donato K., Fioretti F., et al. Autoantibodies in patients with post-COVID syndrome: A possible link with severity? Eur. Rev. Med. Pharmacol. Sci. 2023;27:48&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">38112956</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum D.C., June C.H. Cytokine Storm. N. Engl. J. Med. 2020;383:2255&#x2013;2273. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Fan Y., Alwalid O., Li N., Jia X., Yuan M., Li Y., Cao Y., Gu J., Wu H., et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology. 2021;299:E177&#x2013;E186. doi: 10.1148/radiol.2021203153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203153</ArticleId><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., Heightman M., Hillman T.E., Jacob J., Jarvis H.C. &#x2018;Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson C.L., Broadley T. Long COVID&#x2014;Unravelling a complex condition. Lancet Respir. Med. 2023;11:667&#x2013;668. doi: 10.1016/S2213-2600(23)00232-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00232-1</ArticleId><ArticleId IdType="pubmed">37475126</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehata G.A., Lord K.C., Grudzinski M.C., Elsayed M., Abdelnaby R., Elshabrawy H.A. Neurological Complications of COVID-19: Underlying Mechanisms and Management. Int. J. Mol. Sci. 2021;22:4081. doi: 10.3390/ijms22084081.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22084081</ArticleId><ArticleId IdType="pmc">PMC8071289</ArticleId><ArticleId IdType="pubmed">33920904</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury A., Lyoubi A., Peiffer-Smadja N., de Broucker T., Meppiel E. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev. Neurol. 2021;177:51&#x2013;64. doi: 10.1016/j.neurol.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7832485</ArticleId><ArticleId IdType="pubmed">33446327</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou J.J., Movassaghi M., Gordy D., Olson M.G., Zhang T., Khurana M.S., Chen Z., Perez-Rosendahl M., Thammachantha S., Singer E.J., et al. Neuropathology of COVID-19 (neuro-COVID): Clinicopathological update. Free Neuropathol. 2021;2:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7861505</ArticleId><ArticleId IdType="pubmed">33554218</ArticleId></ArticleIdList></Reference><Reference><Citation>Balachandran H., Phetsouphanh C., Agapiou D., Adhikari A., Rodrigo C., Hammoud M., Shrestha L.B., Keoshkerian E., Gupta M., Turville S. Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses. Cell Rep. 2022;38:110345. doi: 10.1016/j.celrep.2022.110345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.110345</ArticleId><ArticleId IdType="pmc">PMC8768427</ArticleId><ArticleId IdType="pubmed">35090598</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky V.N., Elrashdy F., Aljadawi A., Ali S.M., Khan R.H., Redwan E.M. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How? J. Neurosci. Res. 2021;99:750&#x2013;777. doi: 10.1002/jnr.24752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24752</ArticleId><ArticleId IdType="pmc">PMC7753416</ArticleId><ArticleId IdType="pubmed">33217763</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Li J., Pei S., Lu Y., Li C., Zhu J., Chen R., Wang D., Sun J., Chen K. An updated review of epidemiological characteristics, immune escape, and therapeutic advances of SARS-CoV-2 Omicron XBB.1.5 and other mutants. Front. Cell. Infect. Microbiol. 2023;13:1297078. doi: 10.3389/fcimb.2023.1297078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1297078</ArticleId><ArticleId IdType="pmc">PMC10752979</ArticleId><ArticleId IdType="pubmed">38156316</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A., Thomas N., Ellul M.A., Davies N.W.S., Pollak T.A., Tenorio E.L., Sultan M., Easton A., Breen G., Zandi M., et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study. Lancet Psychiatry. 2020;7:875&#x2013;882. doi: 10.1016/S2215-0366(20)30287-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Health  NIH Study Identifies Features of Long COVID Neurological Symptoms 2023.  [(accessed on 10 February 2024)]; Available online:  https://www.nih.gov/news-events/news-releases/nih-study-identifies-features-long-covid-neurological-symptoms#:~:text=People%20with%20post%2Dacute%20sequelae,fog%2C%E2%80%9D%20or%20cognitive%20impairment.</Citation></Reference><Reference><Citation>Leng A., Shah M., Ahmad S.A., Premraj L., Wildi K., Li Bassi G., Pardo C.A., Choi A., Cho S.M. Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Cells. 2023;12:816. doi: 10.3390/cells12050816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawes M.T., Szenczy A.K., Klein D.N., Hajcak G., Nelson B.D. Increases in depression and anxiety symptoms in adolescents and young adults during the COVID-19 pandemic. Psychol. Med. 2022;52:3222&#x2013;3230. doi: 10.1017/S0033291720005358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291720005358</ArticleId><ArticleId IdType="pmc">PMC7844180</ArticleId><ArticleId IdType="pubmed">33436120</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey S., Biswas P., Ghosh R., Chatterjee S., Dubey M.J., Chatterjee S., Lahiri D., Lavie C.J. Psychosocial impact of COVID-19. Diabetes Metab. Syndr. 2020;14:779&#x2013;788. doi: 10.1016/j.dsx.2020.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.05.035</ArticleId><ArticleId IdType="pmc">PMC7255207</ArticleId><ArticleId IdType="pubmed">32526627</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghaei A., Zhang R., Taylor S., Tam C.-C., Yang C.-H., Li X., Qiao S. Social Life of Females with Persistent COVID-19 Symptoms: A Qualitative Study. Int. J. Environ. Res. Public Health. 2022;19:9076. doi: 10.3390/ijerph19159076.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19159076</ArticleId><ArticleId IdType="pmc">PMC9331983</ArticleId><ArticleId IdType="pubmed">35897448</ArticleId></ArticleIdList></Reference><Reference><Citation>Taube M. Depression and brain fog as long-COVID mental health consequences: Difficult, complex and partially successful treatment of a 72-year-old patient-A case report. Front. Psychiatry. 2023;14:1153512. doi: 10.3389/fpsyt.2023.1153512.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2023.1153512</ArticleId><ArticleId IdType="pmc">PMC10079873</ArticleId><ArticleId IdType="pubmed">37032935</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolivand P., Hosseindoost S., Kolivand Z., Gharaylou Z. Psychosocial impact of COVID-19 2 years after outbreak on mental health of medical workers in Iran. Middle East Curr. Psychiatry. 2023;30:4. doi: 10.1186/s43045-022-00276-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43045-022-00276-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazumi M., Okazaki E., Usuda K., Kataoka M., Nishi D. Relationship between attitudes toward COVID-19 infection, depression and anxiety: A cross-sectional survey in Japan. BMC Psychiatry. 2022;22:798. doi: 10.1186/s12888-022-04474-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-022-04474-1</ArticleId><ArticleId IdType="pmc">PMC9761043</ArticleId><ArticleId IdType="pubmed">36536342</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang E., Su S., Gao S., Liu R., Ding X., Zhang Y., Xie S., Liu J., Yue W., Yin C. Coronavirus Disease 2019 Pandemic-Related Long-Term Chronic Impacts on Psychological Health of Perinatal Women in China. Am. J. Perinatol. 2023;41:e1301&#x2013;e1312. doi: 10.1055/a-2008-4674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-2008-4674</ArticleId><ArticleId IdType="pmc">PMC11132852</ArticleId><ArticleId IdType="pubmed">36603832</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazumi M., Usuda K., Okazaki E., Kataoka M., Nishi D. Differences in the course of depression and anxiety after COVID-19 infection between recovered patients with and without a psychiatric history: A cross-sectional study. Int. J. Environ. Res. Public Health. 2022;19:11316. doi: 10.3390/ijerph191811316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191811316</ArticleId><ArticleId IdType="pmc">PMC9517442</ArticleId><ArticleId IdType="pubmed">36141588</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeelani A., Dkhar S.A., Quansar R., Khan S.S. Prevalence of depression and anxiety among school-going adolescents in Indian Kashmir valley during COVID-19 pandemic. Middle East Curr. Psychiatry. 2022;29:18. doi: 10.1186/s43045-022-00185-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43045-022-00185-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kibria M.G., Kabir R., Rahman U.S., Ahmed S., Amin S., Arafat S. Prevalence and factors associated with depression and anxiety among COVID-19 survivors in Dhaka city. Front. Psychiatry. 2024;15:1280245. doi: 10.3389/fpsyt.2024.1280245.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2024.1280245</ArticleId><ArticleId IdType="pmc">PMC10844488</ArticleId><ArticleId IdType="pubmed">38322144</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosovali B.D., Tezcan B., Aytac I., Tuncer Peker T., Soyal O.B., Mutlu N.M. Anxiety and Depression in the Relatives of COVID-19 and Non-COVID-19 Intensive Care Patients During the Pandemic. Cureus. 2021;13:e20559. doi: 10.7759/cureus.20559.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.20559</ArticleId><ArticleId IdType="pmc">PMC8771297</ArticleId><ArticleId IdType="pubmed">35103138</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao T., Gao D., Lu G., Yi W., Lv Z. Association of gastrointestinal symptoms and skipping breakfast with anxiety and depressive symptoms in quarantined Chinese college students during the Shanghai 2022 lockdown: A cross sectional survey. BMC Psychiatry. 2023;23:889. doi: 10.1186/s12888-023-05317-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-023-05317-3</ArticleId><ArticleId IdType="pmc">PMC10685502</ArticleId><ArticleId IdType="pubmed">38017419</ArticleId></ArticleIdList></Reference><Reference><Citation>Okogbenin E.O., Seb-Akahomen O.J., Edeawe O., Ehimigbai M., Eboreime H., Odike A., Obagaye M.O., Aweh B.E., Erohubie P., Eriyo W., et al. Psychiatric manifestations and associated risk factors among hospitalised patients with COVID-19 in Edo State, Nigeria: A cross-sectional study. BMJ Open. 2022;12:e058561. doi: 10.1136/bmjopen-2021-058561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-058561</ArticleId><ArticleId IdType="pmc">PMC9082729</ArticleId><ArticleId IdType="pubmed">35523500</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindau S.T., Makelarski J.A., Boyd K., Doyle K.E., Haider S., Kumar S., Lee N.K., Pinkerton E., Tobin M., Vu M., et al. Change in Health-Related Socioeconomic Risk Factors and Mental Health during the Early Phase of the COVID-19 Pandemic: A National Survey of U.S. Women. J. Womens Health. 2021;30:502&#x2013;513. doi: 10.1089/jwh.2020.8879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2020.8879</ArticleId><ArticleId IdType="pmc">PMC8064961</ArticleId><ArticleId IdType="pubmed">33818123</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Cancela-Cilleruelo I., Moro-L&#xf3;pez-Menchero P., Rodr&#xed;guez-Jim&#xe9;nez J., Pellicer-Valero O.J. Trajectory curves of post-COVID anxiety/depressive symptoms and sleep quality in previously hospitalized COVID-19 survivors: The LONG-COVID-EXP-CM multicenter study. Psychol. Med. 2023;53:4298&#x2013;4299. doi: 10.1017/S003329172200006X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S003329172200006X</ArticleId><ArticleId IdType="pmc">PMC8770842</ArticleId><ArticleId IdType="pubmed">35000650</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Rodr&#xed;guez-Jim&#xe9;nez J., Palacios-Ce&#xf1;a M., de-la-Llave-Rinc&#xf3;n A.I., Fuensalida-Novo S., Florencio L.L., Ambite-Quesada S., Ortega-Santiago R., Arias-Bur&#xed;a J.L., Liew B.X. Psychometric properties of the Hospital Anxiety and Depression Scale (HADS) in previously hospitalized COVID-19 patients. Int. J. Environ. Res. Public Health. 2022;19:9273. doi: 10.3390/ijerph19159273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19159273</ArticleId><ArticleId IdType="pmc">PMC9367824</ArticleId><ArticleId IdType="pubmed">35954630</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman D.E., Boudrias M.H., Mazer B. Long COVID symptoms in a population-based sample of persons discharged home from hospital. Can. J. Public Health. 2022;113:930&#x2013;939. doi: 10.17269/s41997-022-00695-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.17269/s41997-022-00695-9</ArticleId><ArticleId IdType="pmc">PMC9491248</ArticleId><ArticleId IdType="pubmed">36131218</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter D., Schulze H., James J.C., Siems N., Trampe N., Gold R., Krogias C., Faissner S. Hypoechogenicity of brainstem raphe in long-COVID syndrome-less common but independently associated with depressive symptoms: A cross-sectional study. J. Neurol. 2022;269:4604&#x2013;4610. doi: 10.1007/s00415-022-11154-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11154-3</ArticleId><ArticleId IdType="pmc">PMC9098142</ArticleId><ArticleId IdType="pubmed">35552501</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., He J., Wang Y., Bai M., Zhang Y., Chen H., Li W., Cai Y., Chen S., Qu M., et al. A cross-sectional study on the mental health of patients with COVID-19 1 year after discharge in Huanggang, China. Eur. Arch. Psychiatry Clin. Neurosci. 2023;273:301&#x2013;310. doi: 10.1007/s00406-022-01484-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-022-01484-8</ArticleId><ArticleId IdType="pmc">PMC9529163</ArticleId><ArticleId IdType="pubmed">36192452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang T.J., Rabheru K., Peisah C., Reichman W., Ikeda M. Loneliness and social isolation during the COVID-19 pandemic. Int. Psychogeriatr. 2020;32:1217&#x2013;1220. doi: 10.1017/S1041610220000988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610220000988</ArticleId><ArticleId IdType="pmc">PMC7306546</ArticleId><ArticleId IdType="pubmed">32450943</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein M., Ashkenazi-Hoffnung L., Greenberg D., Dalal I., Livni G., Chapnick G., Stein-Zamir C., Ashkenazi S., Hecht-Sagie L., Grossman Z. The Burden of COVID-19 in Children and Its Prevention by Vaccination: A Joint Statement of the Israeli Pediatric Association and the Israeli Society for Pediatric Infectious Diseases. Vaccines. 2022;10:81. doi: 10.3390/vaccines10010081.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10010081</ArticleId><ArticleId IdType="pmc">PMC8781684</ArticleId><ArticleId IdType="pubmed">35062742</ArticleId></ArticleIdList></Reference><Reference><Citation>Kader N., Elhusein B., Al Abdulla S., Hamza A.H., Al Maslamani M., Chandra P., Perayil R., Vincent J., Gunashekaran J., Alabdulla M. Risk perception and psychological impact of COVID-19 pandemic among healthcare workers in primary and secondary healthcare settings in Qatar: A national study. J. Prim. Care Community Health. 2021;12:21501327211039714. doi: 10.1177/21501327211039714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501327211039714</ArticleId><ArticleId IdType="pmc">PMC8366132</ArticleId><ArticleId IdType="pubmed">34392716</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando H.M., Bennett T.D., Byrd J.B., Bramante C., Callahan T.J., Chute C.G., Davis H.E., Deer R., Gagnier J., Koraishy F.M., et al. Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information. medRxiv. 2021 doi: 10.1101/2021.03.20.21253896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.20.21253896</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiscella K., Sanders M., Yaeger J., editors. JAMA Health Forum. American Medical Association; Chicago, IL, USA: 2022. Strategies to promote equity in COVID-19 antiviral treatment.</Citation><ArticleIdList><ArticleId IdType="pubmed">36218879</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Lu Y., Huang Y.M., Wang M., Ling W., Sui Y., Zhao H.L. Obesity in patients with COVID-19: A systematic review and meta-analysis. Metabolism. 2020;113:154378. doi: 10.1016/j.metabol.2020.154378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154378</ArticleId><ArticleId IdType="pmc">PMC7521361</ArticleId><ArticleId IdType="pubmed">33002478</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang M., Wu X., Jing H., Novakovic V.A., Shi J. The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury. Front. Cardiovasc. Med. 2023;10:1062491. doi: 10.3389/fcvm.2023.1062491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1062491</ArticleId><ArticleId IdType="pmc">PMC9941162</ArticleId><ArticleId IdType="pubmed">36824451</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Chavolla O.Y., Bahena-Lopez J.P., Antonio-Villa N.E., Vargas-Vazquez A., Gonzalez-Diaz A., Marquez-Salinas A., Fermin-Martinez C.A., Naveja J.J., Aguilar-Salinas C.A. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. J. Clin. Endocrinol. Metab. 2020;105:2752&#x2013;2761. doi: 10.1210/clinem/dgaa346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa346</ArticleId><ArticleId IdType="pmc">PMC7313944</ArticleId><ArticleId IdType="pubmed">32474598</ArticleId></ArticleIdList></Reference><Reference><Citation>Landecho M.F., Marin-Oto M., Recalde-Zamacona B., Bilbao I., Fruhbeck G. Obesity as an adipose tissue dysfunction disease and a risk factor for infections&#x2014;COVID-19 as a case study. Eur. J. Intern. Med. 2021;91:3&#x2013;9. doi: 10.1016/j.ejim.2021.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.03.031</ArticleId><ArticleId IdType="pmc">PMC8017564</ArticleId><ArticleId IdType="pubmed">33858724</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsythe C.E., Phinney S.D., Fernandez M.L., Quann E.E., Wood R.J., Bibus D.M., Kraemer W.J., Feinman R.D., Volek J.S. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids. 2008;43:65&#x2013;77. doi: 10.1007/s11745-007-3132-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11745-007-3132-7</ArticleId><ArticleId IdType="pubmed">18046594</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez L.M., Pareja-Galeano H., Sanchis-Gomar F., Emanuele E., Lucia A., Galvez B.G. &#x2018;Adipaging&#x2019;: Ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue. J. Physiol. 2016;594:3187&#x2013;3207. doi: 10.1113/JP271691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP271691</ArticleId><ArticleId IdType="pmc">PMC4908019</ArticleId><ArticleId IdType="pubmed">26926488</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibirica E., De Lorenzo A. Increased Severity of COVID-19 in People with Obesity: Are We Overlooking Plausible Biological Mechanisms? Obesity. 2020;28:1374. doi: 10.1002/oby.22887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.22887</ArticleId><ArticleId IdType="pmc">PMC7273012</ArticleId><ArticleId IdType="pubmed">32403201</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose R.J., Manuel A. Does coronavirus disease 2019 disprove the obesity paradox in acute respiratory distress syndrome? Obesity. 2020;28:1007. doi: 10.1002/oby.22835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.22835</ArticleId><ArticleId IdType="pmc">PMC7262201</ArticleId><ArticleId IdType="pubmed">32294322</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lima J.B., Salazar L., Fernandes A., Teixeira C., Marques L., Afonso C. Long COVID in children and adolescents: A retrospective study in a pediatric cohort. Pediatr. Infect. Dis. J. 2023;42:e109&#x2013;e111. doi: 10.1097/INF.0000000000003829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003829</ArticleId><ArticleId IdType="pmc">PMC9990485</ArticleId><ArticleId IdType="pubmed">36728643</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacavalerie M.R., Pierre-Francois S., Agossou M., Inamo J., Cabie A., Barnay J.L., Neviere R. Obese patients with long COVID-19 display abnormal hyperventilatory response and impaired gas exchange at peak exercise. Future Cardiol. 2022;18:577&#x2013;584. doi: 10.2217/fca-2022-0017.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fca-2022-0017</ArticleId><ArticleId IdType="pmc">PMC9169685</ArticleId><ArticleId IdType="pubmed">35658540</ArticleId></ArticleIdList></Reference><Reference><Citation>Lastra G., Manrique C. Perivascular adipose tissue, inflammation and insulin resistance: Link to vascular dysfunction and cardiovascular disease. Horm. Mol. Biol. Clin. Investig. 2015;22:19&#x2013;26. doi: 10.1515/hmbci-2015-0010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hmbci-2015-0010</ArticleId><ArticleId IdType="pubmed">25941914</ArticleId></ArticleIdList></Reference><Reference><Citation>Denson J.L., Gillet A.S., Zu Y., Brown M., Pham T., Yoshida Y., Mauvais-Jarvis F., Douglas I.S., Moore M., Tea K., et al. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients with COVID-19. JAMA Netw. Open. 2021;4:e2140568. doi: 10.1001/jamanetworkopen.2021.40568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.40568</ArticleId><ArticleId IdType="pmc">PMC8696573</ArticleId><ArticleId IdType="pubmed">34935924</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Yang J., Zhao F., Zhi L., Wang X., Liu L., Bi Z., Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin. Res. Cardiol. 2020;109:531&#x2013;538. doi: 10.1007/s00392-020-01626-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01626-9</ArticleId><ArticleId IdType="pmc">PMC7087935</ArticleId><ArticleId IdType="pubmed">32161990</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahamid M., Nseir W., Khoury T., Mahamid B., Nubania A., Sub-Laban K., Schifter J., Mari A., Sbeit W., Goldin E. Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: A retrospective case-control study. Eur. J. Gastroenterol. Hepatol. 2021;33:1578&#x2013;1581. doi: 10.1097/MEG.0000000000001902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEG.0000000000001902</ArticleId><ArticleId IdType="pmc">PMC8555881</ArticleId><ArticleId IdType="pubmed">32868652</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariyanto T.I., Kurniawan A. Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;14:1463&#x2013;1465. doi: 10.1016/j.dsx.2020.07.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.07.054</ArticleId><ArticleId IdType="pmc">PMC7395301</ArticleId><ArticleId IdType="pubmed">32771919</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J., Zu Y., Alkhatib A., Pham T.T., Gill F., Jang A., Radosta S., Chaaya G., Myers L., Zifodya J.S., et al. Metabolic Syndrome and COVID-19 Mortality Among Adult Black Patients in New Orleans. Diabetes Care. 2020;44:188&#x2013;193. doi: 10.2337/dc20-1714.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-1714</ArticleId><ArticleId IdType="pmc">PMC7783937</ArticleId><ArticleId IdType="pubmed">32843337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lohia P., Kapur S., Benjaram S., Pandey A., Mir T., Seyoum B. Metabolic syndrome and clinical outcomes in patients infected with COVID-19: Does age, sex, and race of the patient with metabolic syndrome matter? J. Diabetes. 2021;13:420&#x2013;429. doi: 10.1111/1753-0407.13157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1753-0407.13157</ArticleId><ArticleId IdType="pmc">PMC8013372</ArticleId><ArticleId IdType="pubmed">33453090</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalle Grave R., Calugi S., Centis E., Marzocchi R., El Ghoch M., Marchesini G. Lifestyle modification in the management of the metabolic syndrome: Achievements and challenges. Diabetes Metab. Syndr. Obes. Targets Ther. 2010;3:373&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3047997</ArticleId><ArticleId IdType="pubmed">21437107</ArticleId></ArticleIdList></Reference><Reference><Citation>Azizi F., Mirmiran P., Momenan A.A., Hadaegh F., Habibi Moeini A., Hosseini F., Zahediasl S., Ghanbarian A., Hosseinpanah F., Members of Tehran L., et al. The effect of community-based education for lifestyle intervention on the prevalence of metabolic syndrome and its components: Tehran lipid and glucose study. Int. J. Endocrinol. Metab. 2013;11:145&#x2013;153. doi: 10.5812/ijem.5443.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/ijem.5443</ArticleId><ArticleId IdType="pmc">PMC3860109</ArticleId><ArticleId IdType="pubmed">24348586</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein S.R., Cozma D., Kamel M., Hamad M., Mohammad M.G., Khan N.A., Saber M.M., Semreen M.H., Steenblock C. Long-COVID, Metabolic and Endocrine Disease. Horm. Metab. Res. 2022;54:562&#x2013;566. doi: 10.1055/a-1878-9307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1878-9307</ArticleId><ArticleId IdType="pmc">PMC9363148</ArticleId><ArticleId IdType="pubmed">35724687</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Health  NIH&#x2019;s Strategic Response 2023.  [(accessed on 15 February 2024)]; Available online:  https://covid19.nih.gov/nih-strategic-response-covid-19#priority-2.</Citation></Reference><Reference><Citation>Srikanth S., Boulos J.R., Dover T., Boccuto L., Dean D. Identification and diagnosis of long COVID-19: A scoping review. Prog. Biophys. Mol. Biol. 2023;182:1&#x2013;7. doi: 10.1016/j.pbiomolbio.2023.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2023.04.008</ArticleId><ArticleId IdType="pmc">PMC10176974</ArticleId><ArticleId IdType="pubmed">37182545</ArticleId></ArticleIdList></Reference><Reference><Citation>Areerob Y., Sagadevan S., Oh W.-C. A comprehensive review and clinical guide to molecular and serological diagnostic tests and future development: In vitro diagnostic testing for COVID-19. Nanotechnol. Rev. 2023;12:20220513. doi: 10.1515/ntrev-2022-0513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/ntrev-2022-0513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Kim S.E., Kim T., Yun K.W., Lee S.H., Lee E., Seo J.W., Jung Y.H., Chong Y.P. Preliminary Guidelines for the Clinical Evaluation and Management of Long COVID. Infect. Chemother. 2022;54:566&#x2013;597. doi: 10.3947/ic.2022.0141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3947/ic.2022.0141</ArticleId><ArticleId IdType="pmc">PMC9533168</ArticleId><ArticleId IdType="pubmed">36196612</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Nicholson T., Akrami A., Apfelbacher C., Chen J., De Groote W., Diaz J.V., Gorst S.L., Harman N., Kokorina A., et al. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: An international Delphi consensus study. Lancet Respir. Med. 2022;10:715&#x2013;724. doi: 10.1016/S2213-2600(22)00169-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00169-2</ArticleId><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab. Syndr. 2021;15:145&#x2013;146. doi: 10.1016/j.dsx.2020.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of COVID-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Duerlund L.S., Shakar S., Nielsen H., Bodilsen J. Positive Predictive Value of the ICD-10 Diagnosis Code for Long-COVID. Clin. Epidemiol. 2022;14:141&#x2013;148. doi: 10.2147/CLEP.S344515.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S344515</ArticleId><ArticleId IdType="pmc">PMC8843419</ArticleId><ArticleId IdType="pubmed">35177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Froidure A., Mahsouli A., Liistro G., De Greef J., Belkhir L., Gerard L., Bertrand A., Koenig S., Pothen L., Yildiz H., et al. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae. Respir. Med. 2021;181:106383. doi: 10.1016/j.rmed.2021.106383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106383</ArticleId><ArticleId IdType="pmc">PMC8019490</ArticleId><ArticleId IdType="pubmed">33839588</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallia P., Meghji J., Wong B., Kumar K., Pilkington V., Chhabra S., Russell B., Chen J., Srikanthan K., Park M., et al. Symptomatic, biochemical and radiographic recovery in patients with COVID-19. BMJ Open Respir. Res. 2021;8:e000908. doi: 10.1136/bmjresp-2021-000908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-000908</ArticleId><ArticleId IdType="pmc">PMC8029037</ArticleId><ArticleId IdType="pubmed">33827856</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B., Tang N., Peluso M.J., Iyer N.S., Torres L., Donatelli J.L., Munter S.E., Nixon C.C., Rutishauser R.L., Rodriguez-Barraquer I., et al. Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells. 2021;10:386. doi: 10.3390/cells10020386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudoran C., Tudoran M., Pop G.N., Giurgi-Oncu C., Cut T.G., Lazureanu V.E., Oancea C., Parv F., Ciocarlie T., Bende F. Associations between the Severity of the Post-Acute COVID-19 Syndrome and Echocardiographic Abnormalities in Previously Healthy Outpatients Following Infection with SARS-CoV-2. Biology. 2021;10:469. doi: 10.3390/biology10060469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10060469</ArticleId><ArticleId IdType="pmc">PMC8226755</ArticleId><ArticleId IdType="pubmed">34073342</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabanoglu C., Inanc I.H., Polat E., Peker S.A. Long-term predictive value of cardiac biomarkers in patients with COVID-19 infection. Eur. Rev. Med. Pharmacol. Sci. 2022;26:6396&#x2013;6403.</Citation><ArticleIdList><ArticleId IdType="pubmed">36111943</ArticleId></ArticleIdList></Reference><Reference><Citation>Motloch L.J., Jirak P., Gareeva D., Davtyan P., Gumerov R., Lakman I., Tataurov A., Zulkarneev R., Kabirov I., Cai B., et al. Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia. Front. Med. 2022;9:906665. doi: 10.3389/fmed.2022.906665.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.906665</ArticleId><ArticleId IdType="pmc">PMC9273888</ArticleId><ArticleId IdType="pubmed">35836945</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez M., Trent E., Goncalves B.S., Pereira D.G., Puri R., Frazier N.A., Sodhi K., Pillai S.S. Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs. Front. Aging Neurosci. 2022;14:1020092. doi: 10.3389/fnagi.2022.1020092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.1020092</ArticleId><ArticleId IdType="pmc">PMC9577202</ArticleId><ArticleId IdType="pubmed">36268187</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Taylor S. NICE guideline on long covid. BMJ. 2020;371:m4938. doi: 10.1136/bmj.m4938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Siso-Almirall A., Brito-Zeron P., Conangla Ferrin L., Kostov B., Moragas Moreno A., Mestres J., Sellares J., Galindo G., Morera R., Basora J., et al. Long COVID-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management. Int. J. Environ. Res. Public Health. 2021;18:4350. doi: 10.3390/ijerph18084350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18084350</ArticleId><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal M.R.H., Bharati S., Podder P. Diagnosis of COVID-19 Using Machine Learning and Deep Learning: A Review. Curr. Med. Imaging. 2021;17:1403&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pubmed">34259149</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul S.G., Saha A., Biswas A.A., Zulfiker M.S., Arefin M.S., Rahman M.M., Reza A.W. Combating COVID-19 using machine learning and deep learning: Applications, challenges, and future perspectives. Array. 2023;17:100271. doi: 10.1016/j.array.2022.100271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.array.2022.100271</ArticleId><ArticleId IdType="pmc">PMC9737520</ArticleId><ArticleId IdType="pubmed">36530931</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff E.R., Girvin A.T., Bennett T.D., Bhatia A., Brooks I.M., Deer R.R., Dekermanjian J.P., Jolley S.E., Kahn M.G., Kostka K., et al. Identifying who has long COVID in the USA: A machine learning approach using N3C data. Lancet Digit. Health. 2022;4:e532&#x2013;e541. doi: 10.1016/S2589-7500(22)00048-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00048-6</ArticleId><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Albaqer H.A., Al-Jibouri K.J., Martin J., Al-Amran F.G., Rawaf S., Yousif M.G. Long-term Neurological Sequelae in Post-COVID-19 Patients: A Machine Learning Approach to Predict Outcomes. arXiv. 2023230909993</Citation></Reference><Reference><Citation>Moore S., Hill E.M., Dyson L., Tildesley M.J., Keeling M.J. Retrospectively modeling the effects of increased global vaccine sharing on the COVID-19 pandemic. Nat. Med. 2022;28:2416&#x2013;2423. doi: 10.1038/s41591-022-02064-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02064-y</ArticleId><ArticleId IdType="pmc">PMC9671807</ArticleId><ArticleId IdType="pubmed">36302894</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E., Levi R., Sarti R., Pozzi C., Mollura M., Mantovani A., Rescigno M. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328:676&#x2013;678. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2022;19:12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S., Zhao Y., Zeng N., Liu X., Zheng Y., Sun J., Zhong Y., Wu S., Ni S., Gong Y., et al. Epidemiology, clinical presentation, pathophysiology, and management of long COVID: An update. Mol. Psychiatry. 2023;28:4056&#x2013;4069. doi: 10.1038/s41380-023-02171-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02171-3</ArticleId><ArticleId IdType="pubmed">37491461</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC)   Interim Clinical Considerations for COVID-19 Treatment and Pre-Exposure Prophylaxis in Outpatients. Centers for Disease Control and Prevention (CDC); Washington, DC, USA: 2024.  [(accessed on 4 April 2024)].  Available online:  https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/outpatient-treatment-overview.html.</Citation></Reference><Reference><Citation>Food and Drug Administration  FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults Washington, D.C.  [(accessed on 4 April 2024)];2023  Available online:  https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-antiviral-treatment-covid-19-adults.</Citation></Reference><Reference><Citation>De Sire A., Moggio L., Marotta N., Agostini F., Tasselli A., Drago Ferrante V., Curci C., Calafiore D., Ferraro F., Bernetti A. Impact of rehabilitation on fatigue in post-COVID-19 patients: A systematic review and meta-analysis. Appl. Sci. 2022;12:8593. doi: 10.3390/app12178593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app12178593</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson P., Wang G., McGarvey L., Vertigan A.E., Altman K.W., Birring S.S., Adams T.M., Barker A.F., Blackhall F., Bolser D.C., et al. Treatment of Unexplained Chronic Cough: CHEST Guideline and Expert Panel Report. Chest. 2016;149:27&#x2013;44. doi: 10.1378/chest.15-1496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.15-1496</ArticleId><ArticleId IdType="pmc">PMC5831652</ArticleId><ArticleId IdType="pubmed">26426314</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell S.A.C., Garrod R., Clark L., Douiri A., Parker S.M., Ellis J., Fowler S.J., Ludlow S., Hull J.H., Chung K.F., et al. Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: A multicentre randomised control trial. Thorax. 2017;72:129&#x2013;136. doi: 10.1136/thoraxjnl-2016-208843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2016-208843</ArticleId><ArticleId IdType="pubmed">27682331</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker A.M., Brigham E., Connolly B., McPeake J., Agranovich A.V., Kenes M.T., Casey K., Reynolds C., Schmidt K.F., Kaplin A., et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: A multidisciplinary model of care. Lancet Respir. Med. 2021;9:1328&#x2013;1341. doi: 10.1016/S2213-2600(21)00385-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00385-4</ArticleId><ArticleId IdType="pmc">PMC8525917</ArticleId><ArticleId IdType="pubmed">34678213</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W.J., Hui C.K.M., Hull J.H., Birring S.S., McGarvey L., Mazzone S.B., Chung K.F. Confronting COVID-19-associated cough and the post-COVID syndrome: Role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir. Med. 2021;9:533&#x2013;544. doi: 10.1016/S2213-2600(21)00125-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00125-9</ArticleId><ArticleId IdType="pmc">PMC8041436</ArticleId><ArticleId IdType="pubmed">33857435</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Health  COVID-19 Treatment Guidelines 2.  [(accessed on 5 April 2024)];2024  Available online:  https://www.covid19treatmentguidelines.nih.gov/</Citation></Reference><Reference><Citation>Khani E., Khiali S., Beheshtirouy S., Entezari-Maleki T. Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review. Eur. J. Pharmacol. 2021;912:174582. doi: 10.1016/j.ejphar.2021.174582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2021.174582</ArticleId><ArticleId IdType="pmc">PMC8524700</ArticleId><ArticleId IdType="pubmed">34678243</ArticleId></ArticleIdList></Reference><Reference><Citation>Joli J., Buck P., Zipfel S., Stengel A. Post-COVID-19 fatigue: A systematic review. Front. Psychiatry. 2022;13:947973. doi: 10.3389/fpsyt.2022.947973.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.947973</ArticleId><ArticleId IdType="pmc">PMC9403611</ArticleId><ArticleId IdType="pubmed">36032234</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaniprabha A., Logeshwaran J., Kiruthiga T., Shah K.B. Examination of the Effects of Long-term COVID-19 Impacts on Patients with Neurological Disabilities Using a Neuro machine Learning Model. BOHR Int. J. Neurol. Neurosci. 2022;1:21&#x2013;28.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>